| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/S0378-4274(00)00201-0 |
| P8608 | Fatcat ID | release_5ur3u7zhbbckdf6xuxgy6w4lh4 |
| P698 | PubMed publication ID | 10906422 |
| P5875 | ResearchGate publication ID | 223894434 |
| P2093 | author name string | Hirota S | |
| Sonobe T | |||
| Sadzuka Y | |||
| P2860 | cites work | Continuous hyperthermic peritoneal perfusion for the prevention of peritoneal recurrence of gastric cancer: randomized controlled study | Q39013638 |
| Activity of amphipathic poly(ethylene glycol) 5000 to prolong the circulation time of liposomes depends on the liposome size and is unfavorable for immunoliposome binding to target | Q41179976 | ||
| Liposomes containing synthetic lipid derivatives of poly(ethylene glycol) show prolonged circulation half-lives in vivo | Q42042312 | ||
| Amphipathic polyethyleneglycols effectively prolong the circulation time of liposomes | Q56386325 | ||
| Diffusion of univalent ions across the lamellae of swollen phospholipids | Q59447717 | ||
| Influence of the steric barrier activity of amphipathic poly(ethyleneglycol) and ganglioside GM1 on the circulation time of liposomes and on the target binding of immunoliposomes in vivo | Q70213084 | ||
| Prophylactic therapy for peritoneal recurrence of gastric cancer by continuous hyperthermic peritoneal perfusion with mitomycin C | Q70369682 | ||
| Determination of the thickness of the fixed aqueous layer around polyethyleneglycol-coated liposomes | Q71567040 | ||
| The Effect of Dose on the Distribution of Adriamycin Encapsulated in Polyethyleneglycol-Coated Liposomes | Q72012018 | ||
| Subcutaneous administration of liposomes: a comparison with the intravenous and intraperitoneal routes of injection | Q72838539 | ||
| Effects of administered route on tissue distribution and antitumor activity of polyethyleneglycol-coated liposomes containing adriamycin | Q73043551 | ||
| Does the amount of an antitumor agent entrapped in liposomes influence its tissue distribution and cell uptake? | Q77674413 | ||
| P433 | issue | 1-2 | |
| P921 | main subject | doxorubicin | Q18936 |
| P304 | page(s) | 51-59 | |
| P577 | publication date | 2000-07-01 | |
| P1433 | published in | Toxicology Letters | Q1796854 |
| P1476 | title | Intraperitoneal administration of doxorubicin encapsulating liposomes against peritoneal dissemination. | |
| P478 | volume | 116 |
| Q26768402 | Chemotherapy for intraperitoneal use: a review of hyperthermic intraperitoneal chemotherapy and early post-operative intraperitoneal chemotherapy |
| Q47968012 | Conventional and long-circulating liposomes of artemisinin: preparation, characterization, and pharmacokinetic profile in mice |
| Q40362494 | Development of stealth liposome formulation of 2'-deoxyinosine as 5-fluorouracil modulator: in vitro and in vivo study |
| Q36301712 | Drug delivery to tumours: recent strategies |
| Q77371423 | Effects of intraperitoneal administration of liposomes and methods of preparing liposomes for local therapy |
| Q36970476 | Enhanced retention of the alpha-particle-emitting daughters of Actinium-225 by liposome carriers |
| Q91670635 | FF-10832 enables long survival via effective gemcitabine accumulation in a lethal murine peritoneal dissemination model |
| Q35212056 | Large anti-HER2/neu liposomes for potential targeted intraperitoneal therapy of micrometastatic cancer |
| Q93949599 | Literature alerts |
| Q90127233 | Numerical modeling of high-intensity focused ultrasound-mediated intraperitoneal delivery of thermosensitive liposomal doxorubicin for cancer chemotherapy |
| Q55135995 | Optimization of drug delivery systems for intraperitoneal therapy to extend the residence time of the chemotherapeutic agent. |
| Q35084128 | Pharmacokinetics and dosimetry of (111)In/(188)Re-labeled PEGylated liposomal drugs in two colon carcinoma-bearing mouse models |
| Q35594864 | Tumoricidal effects of etoposide incorporated into solid lipid nanoparticles after intraperitoneal administration in Dalton's lymphoma bearing mice |
Search more.